1. Home
  2. CRMD vs GILT Comparison

CRMD vs GILT Comparison

Compare CRMD & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • GILT
  • Stock Information
  • Founded
  • CRMD 2006
  • GILT 1987
  • Country
  • CRMD United States
  • GILT Israel
  • Employees
  • CRMD N/A
  • GILT N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • GILT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CRMD Health Care
  • GILT Technology
  • Exchange
  • CRMD Nasdaq
  • GILT Nasdaq
  • Market Cap
  • CRMD 865.2M
  • GILT 894.0M
  • IPO Year
  • CRMD 2010
  • GILT 1993
  • Fundamental
  • Price
  • CRMD $10.59
  • GILT $14.03
  • Analyst Decision
  • CRMD Strong Buy
  • GILT Strong Buy
  • Analyst Count
  • CRMD 8
  • GILT 1
  • Target Price
  • CRMD $17.57
  • GILT $11.00
  • AVG Volume (30 Days)
  • CRMD 2.6M
  • GILT 1.1M
  • Earning Date
  • CRMD 10-29-2025
  • GILT 11-12-2025
  • Dividend Yield
  • CRMD N/A
  • GILT N/A
  • EPS Growth
  • CRMD N/A
  • GILT 12.49
  • EPS
  • CRMD 0.79
  • GILT 0.39
  • Revenue
  • CRMD $121,484,498.00
  • GILT $349,746,000.00
  • Revenue This Year
  • CRMD $480.51
  • GILT $47.18
  • Revenue Next Year
  • CRMD $59.81
  • GILT $13.80
  • P/E Ratio
  • CRMD $13.37
  • GILT $34.61
  • Revenue Growth
  • CRMD 14970.29
  • GILT 19.67
  • 52 Week Low
  • CRMD $5.60
  • GILT $4.83
  • 52 Week High
  • CRMD $17.43
  • GILT $14.65
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 38.35
  • GILT 67.78
  • Support Level
  • CRMD $10.39
  • GILT $13.35
  • Resistance Level
  • CRMD $11.71
  • GILT $14.42
  • Average True Range (ATR)
  • CRMD 0.44
  • GILT 0.64
  • MACD
  • CRMD -0.04
  • GILT -0.02
  • Stochastic Oscillator
  • CRMD 12.34
  • GILT 78.88

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.

Share on Social Networks: